Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Announces Closing of Debt Settlement Agreements

TheNewsWire 1 day ago

Ventripoint Announces New Sales Program to Accelerate Growth in U.S. Market for AI-Powered Echocardiography Solutions

TheNewsWire 4 days ago

Ventripoint Announces Closing of Second and Final Tranche of Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption

TheNewsWire 9 days ago

Ventripoint Announces Amended Non-Brokered Convertible Debenture Private Placement and Shares for Debt Transaction

TheNewsWire November 6, 2024

Ventripoint to debut new AI heart-scanning tech in Europe

Trevor Abes  October 24, 2024

Ventripoint Receives EU CE Mark for Next Generation, AI-powered Heart-scanning Technology

TheNewsWire October 24, 2024

Ventripoint Announces Closing of First Tranche of Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption

TheNewsWire October 18, 2024

Ventripoint Announces Extension of Private Placement Offerings and Upsize of Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption

TheNewsWire October 15, 2024

Ventripoint's Next Generation, AI-powered Heart-Scanning Technology Submitted for EU Medical Device Regulation Certification

TheNewsWire October 11, 2024

Ventripoint Announces Successful Completion of Key Quality Audits

TheNewsWire October 8, 2024

Ventripoint Selected as Trusted Solution for Cardiac Imaging; Featured at the Take Heart Conference

TheNewsWire September 30, 2024

Ventripoint Announces Closing of First Tranche of Non-Brokered Convertible Debenture Private Placement

TheNewsWire September 20, 2024

Ventripoint Announces Filing Amended and Restated Offering Document for Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption

TheNewsWire September 17, 2024

Ventripoint Issues Option Grants and Reports Exercise of Options

TheNewsWire September 9, 2024

Ventripoint to Launch Reference Site Programme to Deepen Collaborations with Hospital Partners

TheNewsWire September 9, 2024

Ventripoint Hires ERG to Provide Investor Relations Services

TheNewsWire September 9, 2024

Ventripoint Announces Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption

TheNewsWire August 29, 2024

Ventripoint Provides Financing Update

TheNewsWire August 28, 2024

Ventripoint Receives Medical Device License from Health Canada to Sell Next Generation, AI-powered, Heart-scanning Technology

TheNewsWire August 21, 2024

Ventripoint's Next Generation, AI-powered Heart-scanning Technology Submitted to Health Canada for Medical Device License

TheNewsWire August 12, 2024